NCT03711812

Brief Summary

The main aim of this study is to determine whether Serratus Anterior Plane (SAP) blockade provides improved pain relief after rib fractures compared to epidural administration of local anaesthetic. The investigators aim to show that SAP catheters (SAPC) can be placed in more situations and are less operator-dependent then thoracic epidural anaesthesia (TEA). This reduces the waiting time required to achieve satisfactory analgesia in the patient. Optimal analgesia allows early respiratory physiotherapy and reduction in the complications of multiple rib fractures. Pain from rib fractures is severe. The sensory nerves of the thoracic wall lie in the SAP and a single ultrasound-guided injection of local anaesthetic spreads widely and provides useful post-injury analgesia for several hours. If a catheter is left in the SAP, the nerve blockade can be maintained for several days. Rib Fracture pain is traditionally treated with oral/ intravenous analgesics or TEA. Opiate analgesia via patient controlled analgesia (PCA) can work very well but it is associated with excessive sedation, constipation, nausea and vomiting. Continuous TEA is generally regarded as the gold standard but it demands monitoring by adequately trained ward staff and is commonly associated with high failure rates and increased risk of complications. SAPC has also been used when TEA and PCA were not desirable. The primary outcome will be the amount of morphine analgesia required by the patient. Secondary outcomes will be pain scores (at rest and on movement), the side effects of morphine, complications of TEA/ SAPC, respiratory function changes and a quality of recovery assessment. The control group will have an epidural block and catheter placed. The treatment group will have SAP blocks and catheters placed under ultrasound guidance. Both blocks will be tested to ensure good pain relief. To avoid potential confounding effects, oral painkillers will adhere strictly to the study protocol.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 8, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 18, 2018

Completed
18 days until next milestone

Study Start

First participant enrolled

November 5, 2018

Completed
7.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
Last Updated

October 14, 2022

Status Verified

October 1, 2022

Enrollment Period

7.1 years

First QC Date

October 8, 2018

Last Update Submit

October 12, 2022

Conditions

Keywords

regional anaesthesiarib fractures

Outcome Measures

Primary Outcomes (1)

  • intravenous morphine use via a patient controlled pump

    This will be measured as the total amount (in milligrams) of intravenous morphine used via a patient controlled pump in 72 hours.

    72 hours

Secondary Outcomes (4)

  • static and dynamic pain scores measurements

    72 hours

  • side effects/ complications of interventions

    72 hours

  • spirometry

    72 hours

  • quality of recovery assessment

    72 hours

Study Arms (2)

Serratus Anterior Plane Catheter

ACTIVE COMPARATOR
Procedure: Serratus Anterior Plane Catheter

Thoracic Epidural

PLACEBO COMPARATOR
Procedure: Thoracic Epidural Catheter

Interventions

Insertion of a Serratus Anterior Plane Catheter to establish a continuous analgesic block with a local anaesthetic infusion

Serratus Anterior Plane Catheter

Insertion of a Thoracic Epidural Catheter to establish a continuous analgesic block with a local anaesthetic infusion

Thoracic Epidural

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged over 18 years suffering 2 or more rib fractures

You may not qualify if:

  • Significant renal dysfunction (baseline creatinine \>150μmol/l - morphine contra- indicated)
  • Pregnancy
  • Patients with chronic pain on regular analgesic medication
  • Patients with significant coagulation abnormality (unsafe to site blocks)
  • Participation in another interventional study that will interact with this trial.
  • Patients unable to give informed consent
  • Hypersensitivity to local anaesthetic (or any other study drug).
  • Contraindication to NSAID (peptic ulceration or sensitive asthma)
  • Weight \<50kg

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Imperial College Healthcare NHS Trust

London, United Kingdom

Location

MeSH Terms

Conditions

Rib Fractures

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesThoracic Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 8, 2018

First Posted

October 18, 2018

Study Start

November 5, 2018

Primary Completion

November 30, 2025

Study Completion

November 30, 2025

Last Updated

October 14, 2022

Record last verified: 2022-10

Locations